HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.

AuthorsGrigory Roginsky, Aimee Alexoff, Eli D Ehrenpreis
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 49 Issue 9 Pg. 794-5 (Oct 2015) ISSN: 1539-2031 [Electronic] United States
PMID26280708 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Narcotic Antagonists
  • Naltrexone
Topics
  • Adult
  • Dose-Response Relationship, Drug
  • Humans
  • Naltrexone (administration & dosage, adverse effects, therapeutic use)
  • Narcotic Antagonists (administration & dosage, adverse effects, therapeutic use)
  • Panniculitis, Peritoneal (drug therapy, physiopathology)
  • Pilot Projects
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: